The Role of Micronutrients in Alopecia Areata: A Review
- 681 Downloads
Alopecia areata (AA) is a common, non-scarring form of hair loss caused by immune-mediated attack of the hair follicle. As with other immune-mediated diseases, a complex interplay between environment and genetics is thought to lead to the development of AA. Deficiency of micronutrients such as vitamins and minerals may represent a modifiable risk factor associated with development of AA. Given the role of these micronutrients in normal hair follicle development and in immune cell function, a growing number of investigations have sought to determine whether serum levels of these nutrients might differ in AA patients, and whether supplementation of these nutrients might represent a therapeutic option for AA. While current treatment often relies on invasive steroid injections or immunomodulating agents with potentially harmful side effects, therapy by micronutrient supplementation, whether as a primary modality or as adjunctive treatment, could offer a promising low-risk alternative. However, our review highlights a need for further research in this area, given that the current body of literature largely consists of small case–control studies and case reports, which preclude any definite conclusions for a role of micronutrients in AA. In this comprehensive review of the current literature, we found that serum vitamin D, zinc, and folate levels tend to be lower in patients with AA as compared to controls. Evidence is conflicting or insufficient to suggest differences in levels of iron, vitamin B12, copper, magnesium, or selenium. A small number of studies suggest that vitamin A levels may modify the disease. Though understanding of the role for micronutrients in AA is growing, definitive clinical recommendations such as routine serum level testing or therapeutic supplementation call for additional studies in larger populations and with a prospective design.
KeywordsHair Loss Alopecia Areata Calcipotriol Serum Zinc Level Squaric Acid
Compliance with Ethical Standards
Conflict of interest
Dr. Qureshi serves as a consultant for Abbvie, Amgen, the Centers for Disease Control and Prevention, Janssen, Merck, Novartis, and Pfizer, and is an investigator for Amgen, Regeneron, and Sanofi. Mr. Thompson, Ms. Mirza, Dr. Park, and Dr. Cho have no conflicts of interest.
This work was funded by the Ruth Sauber Medical Scholar Award of Alpert Medical School, Brown University.
- 15.Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary Reference Intakes for Calcium and Vitamin D. Report from the Institute of Medicine of the National Academy of Sciences. Washington (DC): National Academies Press; 2011. pp. 1-4.Google Scholar
- 17.Visser M, Deeg DJH, Lips P, Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766–72. doi: 10.1210/jc.2003-030604.CrossRefPubMedGoogle Scholar
- 24.Chaudhary S, Dutta D, Kumar M, et al. Vitamin D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: an open-labeled randomized controlled trial. Indian J Endocrinol Metab. 2016;20:391–8. doi: 10.4103/2230-8210.179997.CrossRefPubMedPubMedCentralGoogle Scholar
- 48.Vissers WHPM, Berends M, Muys L, et al. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol. 2004;13:106–12. doi: 10.1111/j.0906-6705.2004.00151.x.CrossRefPubMedGoogle Scholar
- 51.Institute of Medicine (US) Panel on Micronutrients. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Report from the Institute of Medicine of the National Academy of Sciences. Washington (DC): National Academies Press; 2001. pp. 82–83,443. doi: 10.17226/10026.
- 56.Amirnia M, Sinafar S, Sinafar H, Nuri M. Assessment of zinc and copper contents in the hair and serum and also superoxide dismutase, glutathion peroxidase and malondi aldehyde in serum in androgenetic alopecia and alopecia areata. Life Sci J. 2013;10:204–9.Google Scholar
- 63.Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Report from the Institute of Medicine of the National Academy of Sciences. Washington DC: National Academies Press; 2000. pp. 285, 325–326. doi: 10.17226/9810.
- 64.Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Report from the Institute of Medicine of the National Academy of Sciences. Washington DC: National Academies Press; 1997. pp. 190–191. doi: 10.17226/5776.
- 66.World Health Organization, Centers for Disease Control and Prevention, Prevention. Assessing the iron status of populations. 2nd ed. Geneva: World Health Organization; 2004.Google Scholar
- 74.Esfandiarpour I, Farajzadeh S, Abbaszadeh M. Evaluation of serum iron and ferritin levels in alopecia areata. Dermatol Online J. 2008;14:21.Google Scholar
- 76.Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Report from the Institute of Medicine of the National Academy of Sciences. Washington DC: National Academies Press; 1998. pp. 306-307, 313. doi: 10.17226/6015.
- 89.Naziroglu M, Kokcam I. Antioxidants and lipid peroxidation status in the blood of patients with alopecia. Cell Biochem Funct. 2000;18:169–73. doi: 10.1002/1099-0844(200009)18:3<169:AID-CBF870>3.0.CO;2-T.CrossRefPubMedGoogle Scholar